Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Tuberculosis, Lung Diseases, HIV Infection is Scopus-indexed (Q4, CiteScore 0.4). Published by INPOL LTM.
Checked against the index lists dated .
ISSN 2220-5071Verify ISSN ↗2522-1094Verify ISSN ↗
Publisher: INPOL LTM
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 146 / 165 | 11th | Q4 |
| Infectious Diseases | 332 / 361 | 8th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q4, CiteScore 0.4.
Tuberculosis, Lung Diseases, HIV Infection is Q4 in Pulmonary and Respiratory Medicine (rank 146 of 165) and Q4 in Infectious Diseases (rank 332 of 361), by CiteScore 2025.
Tuberculosis, Lung Diseases, HIV Infection is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.4, quartile Q4, 11th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.126, quartile Q4, with an H-index of 3.
Tuberculosis, Lung Diseases, HIV Infection is published by INPOL LTM. Its print ISSN is 2220-5071 and its online ISSN is 2522-1094.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Tuberculosis, Lung Diseases, HIV Infection has an h-index of 7 and a 2-year mean of 0.5 citations per paper (OpenAlex). Its Scopus CiteScore is 0.4, quartile Q4. On 2-year citations it ranks #127 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Tuberculosis, Lung Diseases, HIV Infection published 53 papers in 2025; its busiest recent year was 2024 with 105. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2024–2026), authors are most often from Ukraine (95.1%), Indonesia (2.2%) and Moldova (1.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.